![Todd Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Carter
Hoofd Techniek/Wetenschap/O&O bij
VOYAGER THERAPEUTICS, INC.
Vermogen: 502 727 $ op 31-08-2026
Profiel
Todd Carter is currently Chief Scientific Officer at Voyager Therapeutics, Inc. since 2022.
Formerly, Dr. Carter was Senior Director-Biology at BrainCells, Inc. Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Texas A&M University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-02-2026 | 145.718 ( 0,24% ) | 502 727 $ | 31-08-2026 |
Actieve functies van Todd Carter
| Bedrijven | Functie | Begin |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2018 |
Eerdere bekende functies van Todd Carter
| Bedrijven | Functie | Einde |
|---|---|---|
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | - |
Opleiding van Todd Carter
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
36
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
